Leveraging the Digital Mammography Image Screening Trial (DMIST) Data for the Evaluation of Computer-Aided Detection (CAD) Devices: A Proposal

摘要

The availability of the large dataset of screen/film and full-field digital mammograms acquired through the Digital Mammography Imaging Screening Trial (DMIST) presents an extraordinary opportunity for the assessment of CAD devices. The National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering at the U.S. National Institutes of Health have engaged FDA scientists in the development of a plan to leverage this imaging resource to benchmark the performance of current CAD systems. In this talk, we will present an initial proposal for utilizing the DMIST data to quantitatively assess current CAD systems. It is our goal to engage the IWDM community and other interested groups in the development of a consensus on acceptable study designs for this purpose.